FONAR Corporation

NASDAQ:FONR

17.4 (USD) • At close September 18, 2024
Bedrijfsnaam FONAR Corporation
Symbool FONR
Munteenheid USD
Prijs 17.4
Beurswaarde 110,112,246
Dividendpercentage 0%
52-weken bereik 12.13 - 24.05
Industrie Medical Devices
Sector Healthcare
CEO Mr. Timothy R. Damadian M.D.
Website https://www.fonar.com

An error occurred while fetching data.

Over FONAR Corporation

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides

Vergelijkbare Aandelen

Atossa Therapeutics, Inc. logo

Atossa Therapeutics, Inc.

ATOS

1.42 USD

INmune Bio, Inc. logo

INmune Bio, Inc.

INMB

5.19 USD

Greenwich LifeSciences, Inc. logo

Greenwich LifeSciences, Inc.

GLSI

14.17 USD

Societal CDMO, Inc. logo

Societal CDMO, Inc.

SCTL

1.1 USD

Rezolute, Inc. logo

Rezolute, Inc.

RZLT

4.87 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)